ID
24783
Descripción
Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease
Palabras clave
Versiones (2)
- 17/8/17 17/8/17 -
- 4/9/17 4/9/17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
17 de agosto de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
prior medication determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
prior medication determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
Descripción
PRIOR MEDICATIONS FOR TREATMENT OF PARKINSON'S DISEASE
Alias
- UMLS CUI-1
- C2826257
- UMLS CUI-2
- C0030567
Descripción
medication
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0013227
Descripción
If not "none" above, specify. Use Generic Name.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013227
Descripción
start date of medication
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0808070
Descripción
stop date of medication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Descripción
If not "continued" above, record the date.
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Descripción
total daily dose of medication
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2348070
Descripción
If "other", specify.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
indication for medication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Descripción
PRIOR MEDICATIONS - NON-PARKINSON'S DISEASE
Alias
- UMLS CUI-1
- C2826257
Descripción
medication
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0013227
Descripción
If not "none" above, specify. Use Generic Name.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013227
Descripción
start date of medication
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0808070
Descripción
stop date of medication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Descripción
If not "continued" above, record the date.
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Descripción
total daily dose of medication
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2348070
Descripción
If "other", specify.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
indication for medication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Similar models
prior medication determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
C0030567 (UMLS CUI-2)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])